Prospects for Leveraging the Microbiota as Medicine for Hypertension
Year: 2024
Type: review
Source: Hypertension
Institutions: Baylor College of Medicine, University of Toledo, Baker Heart and Diabetes Institute, Monash University, Xi'an Jiaotong University, Augusta University, Johns Hopkins University, Johns Hopkins Medicine, Max Delbrück Center, Humboldt-Universität zu Berlin, German Centre for Cardiovascular Research, Charité – Universitätsmedizin Berlin
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funders: American Heart Association, Deutsche Forschungsgemeinschaft, National Natural Science Foundation of China, National Institutes of Health, Medical Research Council, National Health and Medical Research Council, National Institute on Aging, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: G2991726324, G3144296984, G443779809, EXAMINING THE ROLE OF GUT DYSBIOSIS IN OBSTRUCTIVE SLEEP APNEA INDUCED HYPERTENSION., Role of gut commensal Coprococcus comes in angiotensin-converting enzyme inhibitor resistant hypertension, The role of gut microbiota in antihypertensive drug resistance and resistant hypertension, Olfactory Receptor 558 (Olfr558) and Blood Pressure Regulation in Aging, Targeting the gut microbiota to treat cardiovascular disease, Role of neutrophil extracellular traps (NETs) in Inflammatory bowel disease
OpenAlex ID: W4394872573